BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Boundless Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.31−0.03 (-1.28%)
Close on Oct 19, 2026
- Market cap
- $51.86M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Boundless Bio has not reported a dividend
No dividend per share appears in Boundless Bio's annual filings since fiscal 2022.